FindTrial
Sign In

Effect of Aerobic Eexercise at different times of day on severity of obstructive sleep apnea, blood pressure and cardiac autonomic modulation in Obstructive Sleep Apnea patients

Effect of Moderate Intensity Aerobic Exercise sessions prescribed at different times of day on severity of Obstructive Sleep Apnea, blood pressure and cardiac autonomic modulation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-10zrb5sh
Enrollment
Unknown
Registered
2023-09-22
Start date
2021-01-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep apnea, Obsutructive

Interventions

This is a randomized crossover clinical trial. A total of 12 patients with obstructive sleep apnea who fulfill the eligibility criteria will undergo four randomized experimental sessions by generating
G11.427.410.698.277

Sponsors

Complexo Hospitalar Hospital Universitário Oswaldo Cruz - HUOC/Pronto-Socorro Cardiológico de Pernambuco - PROCAPE
Lead Sponsor
Universidade de Pernambuco
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Prior diagnosis of Obstructive Sleep Apnea - OSA (apnea hipopnea index above five events/hour); overweight; be aged above eighteen years; both genders

Exclusion criteria

Exclusion criteria: Having uncontrolled high blood pressure; cerebrovascular disease; kidney failure; arrhythmias; musculoskeletal limitations that compromise exercise performance; adhere to another treatment for Obstructive Sleep Apnea - OSA; did not complete the four experimental sessions

Design outcomes

Primary

MeasureTime frame
It is expected to find a mean difference in apnea-hipopnea index of at least 8 events/hour. Will be evaluated through polysomnography at home (ApneaLinkTM).—

Secondary

MeasureTime frame
It is expected to find a mean difference in systolic and diastolic blood pressure of at least 6 mmHg and 3 mmHg, respectively. Assessment will be made by an autonomic monitor (Omron HEM 742). As well as, central blood pressure will also be assessed. Furthermore, the effect of experimental sessions on cardiac autonomic modulation will be evaluated using the heart rate variability technique.—

Countries

Brazil

Contacts

Public ContactJosé Aguair

Complexo Hospitalar HUOC/PROCAPE

jose.porto@ufpe.br+55(81)31817179

Outcome results

None listed

Source: REBEC (via WHO ICTRP)